J. Reeves

609 total citations
11 papers, 463 citations indexed

About

J. Reeves is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, J. Reeves has authored 11 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in J. Reeves's work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lung Cancer Treatments and Mutations (3 papers). J. Reeves is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lung Cancer Treatments and Mutations (3 papers). J. Reeves collaborates with scholars based in United Kingdom. J. Reeves's co-authors include T Cooke, Peter Stanton, Anna Lanigan, John M.S. Bartlett, John A. Duncan, Mark A. Underwood, Rodney J. Scott, TG Cooke, Alison Lannigan and Brad Ozanne and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

J. Reeves

10 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Reeves United Kingdom 9 266 192 136 96 81 11 463
Astrid Mayer United Kingdom 8 367 1.4× 179 0.9× 109 0.8× 53 0.6× 67 0.8× 14 557
Jane Mayotte United States 11 158 0.6× 159 0.8× 48 0.4× 70 0.7× 42 0.5× 14 446
S. Bhattacharya United States 9 278 1.0× 144 0.8× 32 0.2× 143 1.5× 71 0.9× 16 557
Lisa Fichtel United States 11 163 0.6× 106 0.6× 103 0.8× 106 1.1× 52 0.6× 18 499
RD Hunter United Kingdom 7 160 0.6× 272 1.4× 136 1.0× 150 1.6× 39 0.5× 10 598
David Browell United Kingdom 13 277 1.0× 286 1.5× 54 0.4× 129 1.3× 52 0.6× 26 608
Gianni Capalbo Germany 11 185 0.7× 245 1.3× 56 0.4× 60 0.6× 72 0.9× 15 431
Motoko Omura‐Minamisawa Japan 12 126 0.5× 215 1.1× 72 0.5× 102 1.1× 27 0.3× 18 418
A. Staroselsky Israel 13 181 0.7× 179 0.9× 45 0.3× 76 0.8× 55 0.7× 21 501
Liesbeth M. Veenendaal Netherlands 9 152 0.6× 166 0.9× 42 0.3× 95 1.0× 94 1.2× 13 467

Countries citing papers authored by J. Reeves

Since Specialization
Citations

This map shows the geographic impact of J. Reeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Reeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Reeves more than expected).

Fields of papers citing papers by J. Reeves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Reeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Reeves. The network helps show where J. Reeves may publish in the future.

Co-authorship network of co-authors of J. Reeves

This figure shows the co-authorship network connecting the top 25 collaborators of J. Reeves. A scholar is included among the top collaborators of J. Reeves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Reeves. J. Reeves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tan, Zhenda, et al.. (2007). Mukaiyama Aldol Reactions Catalyzed by N-Heterocyclic Carbenes. Synfacts. 2007(5). 544–544.
2.
Reeves, J., et al.. (2006). Low expression of HER2 protein in breast cancer is biologically significant. The Journal of Pathology. 210(3). 358–362. 10 indexed citations
3.
Fraser, Jennifer A., J. Reeves, Peter Stanton, et al.. (2003). A role for BRCA1 in sporadic breast cancer. British Journal of Cancer. 88(8). 1263–1270. 37 indexed citations
4.
Cooke, T, J. Reeves, Alison Lannigan, & Peter Stanton. (2001). The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker. European Journal of Cancer. 37. 3–10. 54 indexed citations
5.
Cooke, T, J. Reeves, Anna Lanigan, & Peter Stanton. (2001). HER2 as a prognostic and predictive marker for breast cancer. Annals of Oncology. 12. S23–S28. 122 indexed citations
6.
Cooke, T, et al.. (1999). Quantitation of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancer. European Journal of Cancer. 35. S203–S203. 9 indexed citations
7.
Cooke, T, J. Reeves, W.D. George, et al.. (1999). Quantitation of c-erbB-2 in primary breast cancer allows identification of a further poor prognostic group. European Journal of Cancer. 35. S89–S89. 3 indexed citations
8.
Duncan, John A., J. Reeves, & T Cooke. (1998). BRCA1 and BRCA2 proteins: roles in health and disease.. Molecular Pathology. 51(5). 237–247. 51 indexed citations
9.
Robertson, Kevin, J. Reeves, Gillian Smith, et al.. (1996). Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.. PubMed. 56(16). 3823–30. 72 indexed citations
10.
Underwood, Mark A., et al.. (1995). C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?. PubMed. 55(11). 2422–30. 97 indexed citations
11.
Reeves, J., et al.. (1963). Fat absorption from the human gastrointestinal tract in patients undergoing teletherapy.. PubMed. 89. 122–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026